TrademarkDir
IPSEN INNOVATION FOR PATIENT CARE
DEAD

Serial Number

88377384

Owner

IPSEN S.A.

Attorney

Ben Natter & William S. Frommer

First Use Date

Nov 30, 2007

Filing Date

Apr 9, 2019

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

IPSEN INNOVATION FOR PATIENT CARE Trademark

Serial Number: 88377384

IPSEN INNOVATION FOR PATIENT CARE is a trademark filed by IPSEN S.A. on April 9, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

IPSEN S.A. (46 trademarks)

65 QUAI GEORGES GORSE
BOULOGNE-BILLANCOURT 92100 , FR

Entity Type: 03

Trademark Details

Filing Date

April 9, 2019

Registration Date

Not Registered

First Use Anywhere

November 30, 2007

First Use in Commerce

November 30, 2007

Published for Opposition

July 23, 2019

Filing History

ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 27, 2023 MAB2
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Apr 27, 2023 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 27, 2023 ABN2
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 13, 2022 GNRN
NON-FINAL ACTION E-MAILED
Oct 13, 2022 GNRT
SU - NON-FINAL ACTION - WRITTEN
Oct 13, 2022 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Sep 21, 2022 SUPC
USE AMENDMENT FILED
Sep 16, 2022 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 16, 2022 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 11, 2022 EXRA
SOU EXTENSION 5 GRANTED
Mar 10, 2022 EX5G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Mar 10, 2022 AITU
SOU EXTENSION 5 FILED
Mar 1, 2022 EXT5
SOU TEAS EXTENSION RECEIVED
Mar 1, 2022 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 20, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2022 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 6, 2022 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 6, 2022 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 6, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 6, 2022 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 30, 2021 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 30, 2021 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 30, 2021 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 30, 2021 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 30, 2021 TCCA
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Dec 30, 2021 EWAF
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 30, 2021 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 30, 2021 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 7, 2021 EXRA
SOU EXTENSION 4 GRANTED
Sep 3, 2021 EX4G
SOU EXTENSION 4 FILED
Sep 3, 2021 EXT4
SOU TEAS EXTENSION RECEIVED
Sep 3, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 26, 2021 EXRA
SOU EXTENSION 3 GRANTED
Feb 24, 2021 EX3G
SOU EXTENSION 3 FILED
Feb 24, 2021 EXT3
SOU TEAS EXTENSION RECEIVED
Feb 24, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Aug 19, 2020 EXRA
SOU EXTENSION 2 GRANTED
Aug 17, 2020 EX2G
SOU EXTENSION 2 FILED
Aug 17, 2020 EXT2
SOU TEAS EXTENSION RECEIVED
Aug 17, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 4, 2020 EXRA
SOU EXTENSION 1 GRANTED
Mar 2, 2020 EX1G
SOU EXTENSION 1 FILED
Mar 2, 2020 EXT1
SOU TEAS EXTENSION RECEIVED
Mar 2, 2020 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sep 17, 2019 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jul 23, 2019 NPUB
PUBLISHED FOR OPPOSITION
Jul 23, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 3, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 17, 2019 CNSA
ASSIGNED TO EXAMINER
Jun 17, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 25, 2019 NWOS
NEW APPLICATION ENTERED
Apr 12, 2019 NWAP

Related Trademarks

More from this Owner

IPSEN BIOSCIENCE

IPSEN BIOSCIENCE

IPSEN BIOSCIENCE

IPSEN BIOSCIENCE

IPSEN BIOPHARMACEUTICALS

IPSEN BIOPHARMACEUTICALS

IPSEN BIOPHARMACEUTICALS

IPSEN BIOPHARMACEUTICALS

IPSEN INNOVATION FOR PATIENT CARE

IPSEN INNOVATION FOR PATIENT CARE

IPSEN INNOVATION FOR PATIENT CARE

IPSEN INNOVATION FOR PATIENT CARE